At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ICU SeaStar Medical Holding Corporation
Pre-Mkt 04-29 05:49:05 EDT
3.92
+0.11
+2.89%
High4.01Low3.72Vol28.23K
Open3.75D1 Closing3.81Amplitude7.72%
Mkt Cap15.66MTradable Cap15.49MTotal Shares3.99M
T/O109.26KT/O Rate0.71%Tradable Shares3.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

SeaStar Medical securities class action dismissed with prejudice, court order shows
Reuters  ·  04:17
SeaStar Medical securities class action dismissed with prejudice, court order shows
ICU Medical Is Maintained at Overweight by Keybanc
Dow Jones  ·  04-27 22:18
ICU Medical Is Maintained at Overweight by Keybanc
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
GlobeNewswire  ·  04-24
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
GlobeNewswire  ·  04-23
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
ICU Medical Is Maintained at Overweight by Piper Sandler
Dow Jones  ·  04-18
ICU Medical Is Maintained at Overweight by Piper Sandler
ICU Medical (ICUI) Gets a Buy from Piper Sandler
TIPRANKS  ·  04-17
ICU Medical (ICUI) Gets a Buy from Piper Sandler
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
TIPRANKS  ·  04-17
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
Sedana Medical Posts Record Sales and Advances Toward U.S. ICU Sedation Market
TIPRANKS  ·  04-15
Sedana Medical Posts Record Sales and Advances Toward U.S. ICU Sedation Market
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
GlobeNewswire  ·  04-14
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)
TIPRANKS  ·  04-14
Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)
Does ICU Medical's (ICUI) New 25% Meeting Threshold Clarify or Complicate Its Governance Story?
Simply Wall St.  ·  04-14
Does ICU Medical's (ICUI) New 25% Meeting Threshold Clarify or Complicate Its Governance Story?
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
TIPRANKS  ·  04-03
Bayer’s ARDS ICU Study Shines Light on Long-Term Risks and Costs
SeaStar Medical showcases new data from SAVE Registry
TIPRANKS  ·  03-30
SeaStar Medical showcases new data from SAVE Registry
SeaStar Medical reports 69% survival in pediatric AKI registry for QUELIMMUNE therapy
Reuters  ·  03-30
SeaStar Medical reports 69% survival in pediatric AKI registry for QUELIMMUNE therapy
Grandfather's 105-Day Cross-City Journey to Visit Wife in ICU Ends as 'World's Best Grandma' Passes Away
Deep News  ·  03-29
Grandfather's 105-Day Cross-City Journey to Visit Wife in ICU Ends as 'World's Best Grandma' Passes Away
SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate
Benzinga  ·  03-26
SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate
Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Dow Jones  ·  03-26
Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Is Push For Easier Special Meetings Altering The Investment Case For ICU Medical (ICUI)?
Simply Wall St.  ·  03-25
Is Push For Easier Special Meetings Altering The Investment Case For ICU Medical (ICUI)?
SeaStar Medical Holding Corp expected to post a loss of $1.06 a share - Earnings Preview
Reuters  ·  03-24
SeaStar Medical Holding Corp expected to post a loss of $1.06 a share - Earnings Preview
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
GlobeNewswire  ·  03-19
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

Introduction

Company Name.
SeaStar Medical Holding Corporation
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.
Issue price:
--